The Fifty-third World Health Assembly,Recalling resolution WHA51.18 on noncommunicable disease prevention and controlrequesting the Director-General to formulate a global strategy for the prevention and control ofnoncommunicable diseases and to submit the proposed global strategy anda plan for implementationto the Executive Board and Health Assembly;Recognizing the enormous human suffering caused by noncommunicable diseases such ascardiovascular diseases, cancer, diabetes and chronic respiratory diseases, and the threat they pose tothe economies of many Member States, leading to increasing health inequalities between countries andpopulations;Noting that the conditions in which people live and their lifestyles influence their health andquality of life, and that the most prominent noncommunicable diseases are linked to common riskfactors, namely, tobacco use, alcohol abuse, unhealthy diet, physical inactivity, environmentalcarcinogens and being aware that these risk factors have economic, social, gender, political,behavioural and environmental determinants;Reaffirming that the global strategy for the prevention and control of noncommunicablediseases and the ensuing implementation plan are directed at reducing premature mortality andimproving quality of life;Recognizing the leadership role that WHO should play in promoting global action againstnoncommunicable diseases and its contribution to global health based on its advantages compared toother organizations,1. URGES Member States:(1) to develop a national policy framework taking into account several policy instrumentssuch as healthy public policies creating a conducive environment for healthy lifestyles; fiscaland taxation policies towards healthy and unhealthy goods and services; and public mediapolicies empowering the community;(2) to establish programmes, at national or any other appropriate level, in the framework ofthe global strategy for the prevention and control of major noncommunicable diseases, andspecifically:WHA53.172(a) to develop a mechanism to provide evidence-based information for policy-making,advocacy, programme monitoring and evaluation;(b) to assess and monitor mortality and morbidity attributable to noncommunicabledisease, and the level of exposure to risk factors and their determinants in the population,by strengthening the health information system;(c) to continue pursuit of intersectoral and cross-cutting health goals required forprevention and control of noncommunicable diseases by according noncommunicablediseases priority on the public health agenda;(d) to emphasize the key role of governmental functions, including regulatoryfunctions, when combating noncommunicable diseases, such as development of nutritionpolicy, control of tobacco products, prevention of alcohol abuse and policies to encouragephysical activity;(e) to promote community-based initiatives for prevention of noncommunicablediseases, based ona comprehensive risk-factor approach;(f) based on available evidence, to support the development of clinical guidelines forcost-effective screening, diagnosis and treatment of common noncommunicable diseases;(g) appropriate health promotion strategies be included in school health programmesand in programmes geared to youth.(3) to promote the effectiveness of secondary and tertiary prevention, including rehabilitationand long-term care, and to ensure that health care systems are responsive to chronicnoncommunicable diseases and that their management is based on cost-effective health careinterventions and equitable access;(4) to share their national experiences and to build the capacity at regional, national andcommunity levels for the development, implementation and evaluation of programmes for theprevention and control of noncommunicable diseases;2. REQUESTS the Director-General:(1) to continue giving priority to the prevention and control of noncommunicable diseases,with special emphasis on developing countries and other deprived populations;(2) to ensure that the leadership provided by WHO in combating noncommunicable diseasesand their risk factors is based on the best available evidence, and thus to facilitate, withinternational partners, capacity building and establishment of a global network of informationsystems;(3) to provide technical support and appropriate guidance to Member States in assessing theirneeds, developing effective health promotion programmes, adapting their health care systems,and addressing gender issues related to the growing epidemic of noncommunicable diseases;(4) to strengthen existing partnerships and develop new ones, notably with specializednational and international nongovernmental organizations, with a view to sharingresponsibilities for implementation of the global strategy based on each partners expertise;WHA53.173(5) to coordinate, in collaboration with the international community, global partnerships andalliances for resource mobilization, advocacy, capacity building and collaborative research;(6) to promote the adoption of international intersectoral policies, regulations and otherappropriate measures that minimize the effect of the major risk factors of noncommunicablediseases;(7) to promote and initiate collaborative research on noncommunicable diseases, includingresearch on behavioural determinants and to strengthen the role of WHO collaborating centresin supporting implementation of the global prevention and control strategy;(8) to pursue dialogue with the pharmaceutical industry, with a view to improvingaccessibility to drugs to collectively treat major noncommunicable diseases and theirdeterminants.Eighth plenary meeting, 20 May 2000A53 / VR / 8= = =